ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; CKD, chronic kidney disease; DASH, Dietary Approaches to Stop Hypertension; HBP, high blood pressure; QCDR, Qualified Clinical Data Registry; SBP, systolic blood pressure; and SDM, shared decision making. 27 Appendix A. Continued Short Title: QM-2: Nonpharmacological Interventions for ACC/AHA Stage 1 HBP QM-2: Percentage of Adults 18 to 85 Years of Age Who Had a Diagnosis of ACC/AHA Stage 1 HBP Who Have a Documented Discussion of Intensive Lifestyle Modification in 1 Visits During the Measurement Year Measure Description: Percentage of patients with ACC/AHA stage 1 HBP who have a documented discussion of intensive lifestyle modification in 1 visits during the measurement year Numerator Patients who have a documented discussion of intensive lifestyle modification at least once in the performance year and in accordance with ACC/AHA guidelines on nonpharmacological therapy Denominator All patients 18 85 y of age with ACC/AHA stage 1 HBP who had at least 1 outpatient encounter with a diagnosis of HBP during the first 6 mo of the measurement year or any time before the measurement period Denominator Exclusions Pregnancy, BP readings taken during an inpatient stay Denominator Exceptions None Measurement Period 12 mo/measurement year Sources of Data Paper medical record/prospective data collection flow sheet, Qualified Electronic Health Record, QCDR, electronic administrative data (claims), expanded (multiple source) administrative data, electronically or telephonically transmitted BP readings Attribution Physician group practice, accountable care organization, clinically integrated network, health plan, integrated delivery system Care Setting Outpatient (office, clinic, home, or ambulatory) Rationale Effective management of ACC/AHA stage 1 hypertension requires intensive lifestyle modification. Among patients with ACC/AHA stage 1 hypertension with ASCVD risk 10%, nonpharmacological therapy should be used in addition to pharmacological therapy as first-line therapy. 